INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,700,088 | +26.2% | 4,304,954 | +5.4% | 0.01% | +28.6% |
| Q2 2023 | $86,157,514 | -29.6% | 4,083,295 | -43.1% | 0.01% | +16.7% |
| Q1 2023 | $122,316,716 | +62.5% | 7,174,000 | +90.4% | 0.01% | -14.3% |
| Q4 2022 | $75,292,781 | -1.5% | 3,768,407 | +6.2% | 0.01% | -12.5% |
| Q3 2022 | $76,408,000 | +13.0% | 3,547,306 | +3.5% | 0.01% | +14.3% |
| Q2 2022 | $67,609,000 | -14.5% | 3,428,486 | +1.9% | 0.01% | +16.7% |
| Q1 2022 | $79,076,000 | -18.1% | 3,364,938 | -5.1% | 0.01% | -14.3% |
| Q4 2021 | $96,572,000 | -12.4% | 3,545,231 | -11.4% | 0.01% | -22.2% |
| Q3 2021 | $110,218,000 | -10.7% | 4,002,094 | -7.7% | 0.01% | -10.0% |
| Q2 2021 | $123,385,000 | -39.3% | 4,335,406 | -27.4% | 0.01% | -41.2% |
| Q1 2021 | $203,336,000 | -49.5% | 5,969,956 | -50.6% | 0.02% | -52.8% |
| Q4 2020 | $402,427,000 | -17.7% | 12,088,544 | -20.6% | 0.04% | -26.5% |
| Q3 2020 | $489,239,000 | +19.0% | 15,222,106 | +1.9% | 0.05% | +8.9% |
| Q2 2020 | $411,279,000 | +90.5% | 14,933,881 | +10.9% | 0.04% | +50.0% |
| Q1 2020 | $215,863,000 | -32.5% | 13,466,134 | +0.5% | 0.03% | -14.3% |
| Q4 2019 | $320,028,000 | +42.4% | 13,401,528 | +5.2% | 0.04% | +29.6% |
| Q3 2019 | $224,773,000 | -17.1% | 12,742,289 | +20.3% | 0.03% | -15.6% |
| Q2 2019 | $271,071,000 | -19.8% | 10,588,716 | -9.0% | 0.03% | -20.0% |
| Q1 2019 | $338,107,000 | +122.9% | 11,630,784 | +0.6% | 0.04% | +90.5% |
| Q4 2018 | $151,714,000 | -35.1% | 11,563,534 | +0.1% | 0.02% | -19.2% |
| Q3 2018 | $233,666,000 | -14.0% | 11,556,128 | +0.5% | 0.03% | -16.1% |
| Q2 2018 | $271,820,000 | +5.0% | 11,493,470 | +0.0% | 0.03% | 0.0% |
| Q1 2018 | $258,816,000 | -27.7% | 11,492,691 | +0.0% | 0.03% | -26.2% |
| Q4 2017 | $358,216,000 | +0.0% | 11,488,651 | +0.1% | 0.04% | -2.3% |
| Q3 2017 | $358,133,000 | +124.3% | 11,474,934 | +23.3% | 0.04% | +115.0% |
| Q2 2017 | $159,653,000 | -2.0% | 9,303,816 | +0.0% | 0.02% | -4.8% |
| Q1 2017 | $162,905,000 | +32.7% | 9,303,517 | +0.2% | 0.02% | +31.2% |
| Q4 2016 | $122,796,000 | -8.9% | 9,281,685 | 0.0% | 0.02% | -11.1% |
| Q3 2016 | $134,770,000 | +62.1% | 9,281,685 | +10.1% | 0.02% | +63.6% |
| Q2 2016 | $83,147,000 | -29.3% | 8,432,774 | -9.1% | 0.01% | -31.2% |
| Q1 2016 | $117,561,000 | -30.1% | 9,278,632 | +0.1% | 0.02% | -30.4% |
| Q4 2015 | $168,260,000 | -2.2% | 9,270,562 | +0.1% | 0.02% | -4.2% |
| Q3 2015 | $172,033,000 | -23.6% | 9,264,039 | +0.4% | 0.02% | -17.2% |
| Q2 2015 | $225,281,000 | +25.7% | 9,225,265 | +7.1% | 0.03% | +26.1% |
| Q1 2015 | $179,245,000 | +55.5% | 8,617,514 | +15.7% | 0.02% | +53.3% |
| Q4 2014 | $115,248,000 | +22.2% | 7,449,749 | +3.1% | 0.02% | +15.4% |
| Q3 2014 | $94,305,000 | -19.9% | 7,226,458 | +22.7% | 0.01% | -18.8% |
| Q2 2014 | $117,700,000 | +5.0% | 5,890,875 | +0.0% | 0.02% | 0.0% |
| Q1 2014 | $112,135,000 | +12.4% | 5,889,436 | +0.4% | 0.02% | +14.3% |
| Q4 2013 | $99,788,000 | +24.1% | 5,866,436 | +13.9% | 0.01% | +16.7% |
| Q3 2013 | $80,410,000 | +78.9% | 5,151,187 | +37.1% | 0.01% | +71.4% |
| Q2 2013 | $44,940,000 | – | 3,757,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |